[4-[(4-Methoxyphenyl)-(4-methylphenyl)phosphanyl]phenyl]methanol

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: [4-[(4-Methoxyphenyl)-(4-methylphenyl)phosphanyl]phenyl]methanol
• 英文别名: [4-[(4-methoxyphenyl)-(4-methylphenyl)phosphanyl]phenyl]methanol
• 化学式: C₂₁H₂₁O₂P
• 分子量: 336.4
• InChiKey: BTYFUKSNOIOCQV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF
  申请人：BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY

  公开号：US20140142067A1

  公开（公告）日：2014-05-22

  The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.
• Compounds for the Treatment of Diabetes and Disease Complications Arising from Same
  申请人：BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY

  公开号：US20160263124A1

  公开（公告）日：2016-09-15

  The present invention is directed to use of a series of tri-aryl compounds and compositions comprising the same for the treatment of diabetes and disease conditions arising as a consequence of the same.
• US9670138B2
  申请人：——

  公开号：US9670138B2

  公开（公告）日：2017-06-06
• US9670139B2
  申请人：——

  公开号：US9670139B2

  公开（公告）日：2017-06-06